Close Menu

NEW YORK — Genetic Technologies said on Wednesday that it has acquired the distribution rights to Taliaz's Predictix line of antidepressant drug selection tools in Australia, New Zealand, and the US.

According to Taliaz, the products analyze various datasets including a patient's genetic and metabolic profiles, clinical history, and demographics to inform prescribing decisions. The Tel Aviv, Israel-based company currently offers Predictix Digital, which focuses on clinical and demographic data, and Predictix Genetics, which uses genetic testing data.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

President-elect Joe Biden has nominated Eric Lander to serve as director of the Office of Science and Technology Policy, the Associated Press says.

Nature News writes that scientists are trying to figure out how to name the new strains of SARS-CoV-2 that are emerging.

The New York Times reports that researchers are studying identical twins who had COVID-19 to understand the influence of genetics on disease severity.

In PNAS this week: epistasis affecting cystic fibrosis, Tiger rattlesnake genome gives venom insight, and more.

Feb
18
Sponsored by
BD

The composition of the immune infiltrate in the human tumor microenvironment is a critical determinant of disease progression.